Skip to content
Recall Observatory FDA recall evidence

Drug product

Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV

D-1292-2022

July 05, 2022

Class I

Product summary

Firm
Mylan Pharmaceuticals Inc
Event
Event 90545
Status
Terminated
Classification
Class I
Quantity
253,200 pens (50,650/5 per packs)
Official record key
drug-enforcement:D-1292-2022

Official wording

Reason: Labeling: Missing label: Label missing from some prefilled pens.

Code information: Lot #: BF21002895, Exp. Date Aug 2023

Distribution pattern: Product was distributed nationwide within the United States

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Missing label: Label missing